Provenienza dei contatti di primo grado di Matthias Breugelmans
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Elastrin Therapeutics, Inc.
 Elastrin Therapeutics, Inc. BiotechnologyHealth Technology Elastrin Therapeutics, Inc. is a biotech company based in Simpsonville, SC. Elastrin Therapeutics is developing novel therapies to reverse cardiovascular disease using a proprietary platform that targets and restores degraded elastin by removing harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting. The company's treatment, a nanoparticle that specifically targets elastin, is able to reverse calcification in the arteries and other tissues, providing a solution to heart disease, stroke, high blood pressure, COPD, and aneurysm. The company was founded by Mirko Stange, Douglas Mulhall, Naren Vyavahare, Charles D. Rice, Valentin Busch, and Markus Zils. The CEO is Matthias Breugelmans.
2
| Holding Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Matthias Breugelmans tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|
Statistiche
Distribuzione geografica
Settori
Posizioni
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Naren Vyavahare | 1 |
| Valentin Busch | 1 |
- Borsa valori
- Insiders
- Matthias Breugelmans
- Connessioni Società
